196 related articles for article (PubMed ID: 7759399)
1. Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis.
Bodmer T; Zürcher G; Imboden P; Telenti A
J Antimicrob Chemother; 1995 Feb; 35(2):345-8. PubMed ID: 7759399
[No Abstract] [Full Text] [Related]
2. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
Yang B; Koga H; Ohno H; Ogawa K; Fukuda M; Hirakata Y; Maesaki S; Tomono K; Tashiro T; Kohno S
J Antimicrob Chemother; 1998 Nov; 42(5):621-8. PubMed ID: 9848446
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Cavusoglu C; Karaca-Derici Y; Bilgic A
Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
[TBL] [Abstract][Full Text] [Related]
4. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
Berrada ZL; Lin SY; Rodwell TC; Nguyen D; Schecter GF; Pham L; Janda JM; Elmaraachli W; Catanzaro A; Desmond E
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):177-81. PubMed ID: 27036978
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.
Dickinson JM; Mitchison DA
Tubercle; 1987 Sep; 68(3):177-82. PubMed ID: 2834842
[TBL] [Abstract][Full Text] [Related]
6. Rifamycin resistance in mycobacteria.
Cole ST
Res Microbiol; 1996; 147(1-2):48-52. PubMed ID: 8761722
[No Abstract] [Full Text] [Related]
7. Mode of Action of Kanglemycin A, an Ansamycin Natural Product that Is Active against Rifampicin-Resistant Mycobacterium tuberculosis.
Mosaei H; Molodtsov V; Kepplinger B; Harbottle J; Moon CW; Jeeves RE; Ceccaroni L; Shin Y; Morton-Laing S; Marrs ECL; Wills C; Clegg W; Yuzenkova Y; Perry JD; Bacon J; Errington J; Allenby NEE; Hall MJ; Murakami KS; Zenkin N
Mol Cell; 2018 Oct; 72(2):263-274.e5. PubMed ID: 30244835
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil.
Valim AR; Rossetti ML; Ribeiro MO; Zaha A
J Clin Microbiol; 2000 Aug; 38(8):3119-22. PubMed ID: 10921994
[TBL] [Abstract][Full Text] [Related]
9. Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
Farhat MR; Sixsmith J; Calderon R; Hicks ND; Fortune SM; Murray M
J Antimicrob Chemother; 2019 Jun; 74(6):1477-1483. PubMed ID: 30793747
[TBL] [Abstract][Full Text] [Related]
10. Rifampicin resistance in tuberculosis outbreak, London, England.
Jenkins C
Emerg Infect Dis; 2005 Jun; 11(6):931-4. PubMed ID: 15963290
[TBL] [Abstract][Full Text] [Related]
11. Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.
Rodríguez JC; Cebrián L; Ruiz M; López M; Royo G
Chemotherapy; 2005 May; 51(2-3):76-9. PubMed ID: 15870500
[TBL] [Abstract][Full Text] [Related]
12. Resistance to rifampicin: a review.
Goldstein BP
J Antibiot (Tokyo); 2014 Sep; 67(9):625-30. PubMed ID: 25118103
[TBL] [Abstract][Full Text] [Related]
13. Detection and Characteristics of Rifampicin-Resistant Isolates of Mycobacterium tuberculosis.
Cherednichenko AG; Dymova MA; Solodilova OA; Petrenko TI; Prozorov AI; Filipenko ML
Bull Exp Biol Med; 2016 Mar; 160(5):659-63. PubMed ID: 27021095
[TBL] [Abstract][Full Text] [Related]
14. Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis.
Siu GK; Zhang Y; Lau TC; Lau RW; Ho PL; Yew WW; Tsui SK; Cheng VC; Yuen KY; Yam WC
J Antimicrob Chemother; 2011 Apr; 66(4):730-3. PubMed ID: 21393153
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of Mycobacterium tuberculosis clinical strains genotype A1].
Stepashina VN; Ivanov IIu; Lipin MIu; Shemiakin IG
Mol Gen Mikrobiol Virusol; 2006; (2):29-33. PubMed ID: 16756000
[TBL] [Abstract][Full Text] [Related]
16. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
J Antimicrob Chemother; 2013 Sep; 68(9):2074-7. PubMed ID: 23633684
[TBL] [Abstract][Full Text] [Related]
17. [Cross-resistance between rifampin and rifabutin in multidrug resistant Mycobacterium tuberculosis complex strains].
Gao L; Xiao HP; Hu ZY; Cui ZL; Lu JM; Shen XN
Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):333-5. PubMed ID: 22883990
[TBL] [Abstract][Full Text] [Related]
18. Isolation of the gene for the beta subunit of RNA polymerase from rifampicin-resistant Mycobacterium tuberculosis and identification of new mutations.
Donnabella V; Martiniuk F; Kinney D; Bacerdo M; Bonk S; Hanna B; Rom WN
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):639-43. PubMed ID: 7946393
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
20. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
